Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-13T01:18:24.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing

Published online by Cambridge University Press:  19 March 2018

Kathleen A. Quan ,
Jennifer Yim ,
Doug Merrill ,
Usme Khusbu ,
Keith Madey ,
Linda Dickey ,
Amish A. Dangodara ,
Scott E. Rudkin ,
Margaret O’Brien  and
Daniel Thompson
...Show all authors
Kathleen A. Quan
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California
Jennifer Yim
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California
Doug Merrill
Affiliation:
Renown Health, Reno School of Medicine, University of Nevada, Reno, Nevada
Usme Khusbu
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California
Keith Madey
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California
Linda Dickey
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California
Amish A. Dangodara
Affiliation:
Department of Medicine, School of Medicine, University of California Irvine, Irvine, California Health Affairs Information Services, School of Medicine, University of California Irvine, Irvine, California
Scott E. Rudkin
Affiliation:
Department of Emergency Medicine, School of Medicine, University of California Irvine, Irvine, California Health Affairs Information Services, School of Medicine, University of California Irvine, Irvine, California
Margaret O’Brien
Affiliation:
Health Affairs Information Services, School of Medicine, University of California Irvine, Irvine, California
Daniel Thompson
Affiliation:
Health Affairs Information Services, School of Medicine, University of California Irvine, Irvine, California
Nimisha Parekh
Affiliation:
Department of Medicine, School of Medicine, University of California Irvine, Irvine, California Division of Gastroenterology, School of Medicine, University of California Irvine, Irvine, California
C. Gregory Albers
Affiliation:
Department of Medicine, School of Medicine, University of California Irvine, Irvine, California Division of Gastroenterology, School of Medicine, University of California Irvine, Irvine, California
William C. Wilson
Affiliation:
Department of Medicine, School of Medicine, University of California Irvine, Irvine, California Department of Anesthesiology, School of Medicine, University of California Irvine, Irvine, California Department of Surgery, School of Medicine, University of California Irvine, Irvine, California
Lauri Thrupp
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California Division of Infectious Diseases and Health Policy Research Institute, School of Medicine, University of California Irvine, Irvine, California
Cassiana E. Bittencourt
Affiliation:
Department of Pathology, School of Medicine, University of California Irvine, Irvine, California.
Susan S. Huang
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California Division of Infectious Diseases and Health Policy Research Institute, School of Medicine, University of California Irvine, Irvine, California
Shruti K. Gohil*
Affiliation:
Epidemiology and Infection Prevention, University of California Irvine Health, Orange, California Division of Infectious Diseases and Health Policy Research Institute, School of Medicine, University of California Irvine, Irvine, California
*
Address correspondence to Shruti K. Gohil, MD, MPH, Assistant Professor, University of California, Irvine, School of Medicine, UC Irvine Health, 101 The City Drive, Bldg 56, Suite 700, Rte 181, Orange, CA 92868 (skgohil@uci.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 5 , May 2018 , pp. 625 - 627
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a

Co-authors of equal contribution.

References

REFERENCES

1. Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med Feb 26 2015;372:825–834.Google Scholar
2. Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med Nov 2015;175:1792–1801.Google Scholar
3. Furuya-Kanamori, L, Clements, AC, Foster, NF, et al. Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional study. Clin Microbiol Infect 2017;23:48 e41–e48.Google Scholar
4. Burnham, CA, Carroll, KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013;26:604–630.Google Scholar
5. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.Google Scholar
6. Surawicz, CM, Brandt, LJ, Binion, DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478–498; quiz 499.Google Scholar
7. Sittig, DF, Singh, H. Electronic health records and national patient-safety goals. N Engl J Med 2012;367:1854–1860.Google Scholar
8. Isaac, S, Scher, JU, Djukovic, A, et al. Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother 2017;72:128–136.Google Scholar
9. Vrieze, A, Out, C, Fuentes, S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol Apr 2014;60:824–831.Google Scholar
10. Al-Nassir, WN, Sethi, AK, Li, Y, Pultz, MJ, Riggs, MM, Donskey, CJ. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile–associated disease. Antimicrob Agents Chemother Jul 2008;52:2403–2406.CrossRefGoogle ScholarPubMed
Supplementary material: Image

Quan et al. supplementary material

Figure 1A

Download Quan et al. supplementary material(Image)
Image 450.4 KB
Supplementary material: Image

Quan et al. supplementary material

Figure 1B

Download Quan et al. supplementary material(Image)
Image 91.7 KB